Can We Use the Word ‘Cure’ for a Subset of Selected Patients With Advanced NSCLC?

Immune Checkpoint Inhibitors Have Led to Substantial Improvements in Lung Cancer but Are Still Not a ‘Cure’

Deeper Dive: A Plethora of Prediction Models

Study Provides Insights That May Inform Prevention, Management of Mesothelioma

IASLC Releases Position Statement on Air Pollution on Earth Day

IASLC Responds to Call for Evidence

Researcher Reveals How Air Pollution May Cause Lung Cancer

Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

In Brief for June 22, 2022

Journal of Thoracic Oncology Impact Factor Surpasses 20

Step It Up For Research!

Foundation Announces 2022 Young Investigator Grant Recipients